Company profile
RephImmune company profile
RephImmune is revolutionizing solid tumor cell therapy through our groundbreaking technology. Unlike conventional cell therapies, RACE bypasses traditional signaling pathways, unlocking the full potential of immune cells. With unparalleled advantages evident in pre-clinical data, RACE stands out in transformative advancements. Join us in accelerating RACE breakthroughs to have a clinical impact on more cancer patients!
Business identity
- Website
- https://www.rephimmune.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2023-01-01
Headquarters
- Headquarters
- Taiwan, Jiangsu, China
- Country code
- CN
- Continent
- Asia